BlackRock Portfolio holdings
BlackRock is an asset manager that runs the iShares family of exchange-traded funds. It was founded in 1988 by Larry Fink, a mortgage-bond pioneer at First Boston, and several colleagues, to manage money for institutions with a focus on risk. Blackstone backed the start-up in exchange for a stake in its bond business, and the two parted ways in 1994. BlackRock went public in 1999 and merged with the investment managers division of Merrill in 2006. BlackRock bought the iShares business from Barclays in 2010 and the private credit manager HPS Investment Partners in 2025. It also sells technology: its Aladdin platform gives institutional investors tools for portfolio management, risk analysis, trading and accounting, and its BlackRock Solutions unit, launched in 2000, advises on risk management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$8.67B |
| 2 |
Microsoft
MSFT
|
+$5.68B |
| 3 |
HONA
Honeywell Aerospace
HONA
|
+$5.24B |
| 4 |
Apple
AAPL
|
+$5.23B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$5.81B |
| 2 |
Coterra Energy
CTRA
|
+$2.24B |
| 3 |
Intel
INTC
|
+$2.13B |
| 4 |
Qualcomm
QCOM
|
+$2.03B |
| 5 |
Hologic
HOLX
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Financials | 11.04% |
| 3 | Industrials | 9.8% |
| 4 | Healthcare | 9.52% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2001
Orchid Island Capital
ORC
$953M
| $143M | ﹤0.01% |
20,540,427
+3,363,860
| +20% | +$23.2M |
2015 Q2
44 quarters
|
|
2002
Hanmi Financial
HAFC
$964M
| $142M | ﹤0.01% |
4,388,542
-56
| -0% | -$1.67K |
2013 Q2
52 quarters
|
|
2003
German American Bancorp
GABC
$1.88B
| $142M | ﹤0.01% |
2,995,249
+288,780
| +11% | +$12.7M |
2013 Q2
52 quarters
|
|
2004
Bank of N.T. Butterfield & Son
NTB
$2.17B
| $142M | ﹤0.01% |
2,386,844
+84,075
| +4% | +$4.76M |
2016 Q4
38 quarters
|
|
2005
BellRing Brands
BRBR
$1.07B
| $142M | ﹤0.01% |
10,935,621
-333,074
| -3% | -$4.02M |
2019 Q4
26 quarters
|
|
2006
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.09B
| $141M | ﹤0.01% |
4,735,636
+2,498,767
| +112% | +$82.7M |
2022 Q2
16 quarters
|
|
2007
Absci
ABSI
$1.75B
| $141M | ﹤0.01% |
12,175,302
+920,108
| +8% | +$5.18M |
2021 Q3
19 quarters
|
|
2008
Taysha Gene Therapies
TSHA
$1.41B
| $141M | ﹤0.01% |
20,691,927
+2,326,319
| +13% | +$13.8M |
2020 Q3
23 quarters
|
|
2009
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.41B
| $141M | ﹤0.01% |
1,170,834
-184,523
| -14% | -$22.3M |
2013 Q2
52 quarters
|
|
2010
NetEase
NTES
$82.9B
| $141M | ﹤0.01% |
1,098,474
+273,407
| +33% | +$32.3M |
2013 Q2
52 quarters
|
|
2011
Liquidity Services
LQDT
$1.37B
| $141M | ﹤0.01% |
3,591,724
+193,181
| +6% | +$6.84M |
2013 Q2
52 quarters
|
|
2012
Palvella Therapeutics
PVLA
$2.53B
| $140M | ﹤0.01% |
918,357
+231,504
| +34% | +$28.1M |
2017 Q1
37 quarters
|
|
2013
Piedmont Realty Trust
PDM
$1.23B
| $140M | ﹤0.01% |
15,297,139
+225,530
| +1% | +$1.86M |
2013 Q2
52 quarters
|
|
2014
Nokia
NOK
$42.9B
| $140M | ﹤0.01% |
10,528,008
+100,271
| +1% | +$1.29M |
2020 Q4
22 quarters
|
|
2015
Aurinia Pharmaceuticals
AUPH
$2.21B
| $139M | ﹤0.01% |
8,193,085
+347,564
| +4% | +$5.55M |
2017 Q4
34 quarters
|
|
2016
Pilgrim's Pride
PPC
$6.79B
| $139M | ﹤0.01% |
4,942,584
+335,485
| +7% | +$10.3M |
2013 Q2
52 quarters
|
|
2017
Summit Therapeutics
SMMT
$13B
| $139M | ﹤0.01% |
9,529,041
-124,717
| -1% | -$2.21M |
2020 Q4
22 quarters
|
|
2018
Under Armour Class C
UA
$2.19B
| $139M | ﹤0.01% |
22,320,434
+5,594,590
| +33% | +$32.2M |
2016 Q2
40 quarters
|
|
2019
TETRA Technologies
TTI
$891M
| $138M | ﹤0.01% |
12,223,413
+612,884
| +5% | +$6M |
2013 Q2
52 quarters
|
|
2020
Trustco Bank Corp NY
TRST
$976M
| $138M | ﹤0.01% |
2,517,431
-48,932
| -2% | -$2.43M |
2013 Q2
52 quarters
|
|
2021
Unilever
UL
$142B
| $138M | ﹤0.01% |
2,293,405
-27,994
| -1% | -$1.62M |
2016 Q4
38 quarters
|
|
2022
Teladoc Health
TDOC
$1.6B
| $138M | ﹤0.01% |
16,223,134
+1,609,578
| +11% | +$10.7M |
2015 Q3
43 quarters
|
|
2023
Cimpress
CMPR
$1.39B
| $137M | ﹤0.01% |
1,349,820
+29,998
| +2% | +$2.67M |
2013 Q2
52 quarters
|
|
2024
Turning Point Brands
TPB
$1.32B
| $137M | ﹤0.01% |
1,618,598
+147,996
| +10% | +$12.3M |
2016 Q2
40 quarters
|
|
2025
CareDx
CDNA
$4.13B
| $137M | ﹤0.01% |
4,814,709
+292,613
| +6% | +$6.37M |
2017 Q1
37 quarters
|
|
Similar funds
BlackRock's Q2 2026 Portfolio in Review
As of Q2 2026, BlackRock held 5,933 positions worth $6.73T, up 18% from $5.72T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BlackRock's Q2 2026 filing shows 245 new, 3,464 increased, 1,293 reduced and 235 closed positions. Its largest new stake was SpaceX: 51,037,137 shares worth $8.72B. The largest sale was Honeywell, an estimated $5.81B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
- BlackRock's largest Q2 2026 buy was SpaceX: 51,037,137 shares worth $8.72B.
- BlackRock added most to Microsoft in Q2 2026, an estimated $5.68B increase.
- BlackRock's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.81B.
- BlackRock fully exited Coterra Energy in Q2 2026, selling an estimated $2.24B.
- BlackRock's ten largest holdings make up 28% of its $6.73T portfolio in Q2 2026.
- BlackRock opened 245 new positions and closed 235 in Q2 2026.
- BlackRock's portfolio value rose 18% quarter-over-quarter to $6.73T.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.